Effect of dexamethasone on striatal neurotransmissions in the rats subjected to parkinson's disease animal model

Iranian Journal of Basic Medical Sciences

Volumn 14, Issue 2, 2011, Pages 107-115

  Amanlou, Massoud ^a   Siadat, Seyed Davar ^b   Norouzian, Dariush ^b   Aghasadeghi, Mohammad Reza ^b   Fathi Moghaddam, Hadi ^c   Piryaei, Mohhamad ^d   Ardestani, Mehdi Shafiee ^a,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dexamethasone; Dopamine; GABA; Glutamate; Parkinson's disease

Indexed keywords

4 AMINOBUTYRIC ACID; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC TRANSMISSION; DRUG EFFECT; DRUG MECHANISM; MALE; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; RAT; SUBSTANTIA NIGRA PARS COMPACTA;

ANIMALIA; PARKINSONIA; RATTUS;

EID: 79955494091     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rowland LP. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 2000; 48:792-795.
2. McGeer PL, McGeer EG. Innate immunity, local inflammation, and degenerative disease. Sci Aging Kowledge Environ 2002; 29 review 3.
3. McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administration. Ann Neurol 2003; 54:599-604.
4. Smith WL, Marnett LJ, Dewitt DL.Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 1991; 49:153-79.
5. Xie WL, Chipman GJ, Robertson DL, Erikson RL.Expression of a mitogenresponsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991; 88:2692-2696.
6. Shaftel SS, Olschowka JA, Hurly SD. COX-3: a splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res Mol Brain Res 2003; 119:153-179.
7. Herschman HR. Prostaglandin synthase-2. Biochem Biophys Acta 1996; 1299:153-179.
8. Dubois RN, Abramson SB, Crofford L, Cupta RA. Cyclooxygenase in biology and disease. FASEB J 1998; 12:1063-1073.
9. Li RC, Row BW, Gozal E, Fan Q, Guo SZ. Cyclooxygenase-2 and intermittent hypoxia-induced spatial defects in the rat. Am J Respir Crit Care Med 2003; 168:469-475.
10. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain disease. J Neuropathol Exp Neural 2004; 63:901-910.
11. Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybylkowski A, Czlonkowski A. Dexamethasone protects against dopaminergic neuron damage in a mouse model of Parkinson's disease. Int Immunopharmacol 2004; 4:1307-1318.
12. Sánchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell L, Isacson O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflammation 2004; 1:6.
13. Mladenovic A, Perovic M, Raicevic N, Kanazir S, Rakic L, Ruzdijic S. 6- Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res 2004; 996:237-245.
14. Shafiee Ardestani M, Mehrab H, Sadeghzadeh N. Effects of dexamethasone and betamethasone on rigidity in a rat model of Parkinson's disease. Indian J Pharmacol 2007; 39:235-239.
15. Shafiee Ardestani M, Hemmati AA, Fathi-Moghaddam H, Nazari Z. Effects of aspirin and celecoxib on rigidity in a rat model of Parkinson's disease. Pak J Biol Sci 2007; 21:3853-3858.
16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press; 1997.
17. Fathi-Moghaddam H, Shafiee Ardestani, M, Saffari M, Navidpour L, Shafiee A, Rahmim A. Dopaminergic but not glutamatergic neurotransmission is increased in the striatum after selective COX-2 inhibition in normal and hemiparkinsonian rats. Basic Clin Pharmacol Toxicol 2008; 103:293-296.
18. Shafiee Ardestani M. Parkinson's disease, the inflammatory pathway and anti inflammatory agents: an overview. J Med Sci 2010; 10:49-58.
19. Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybylkowski A, Czlonkowski A, et al. Dexamethasone protects against dopaminergic neuron damage in a mouse model of Parkinson.s disease. Int Immunopharmacol 2004; 4:1307-1318.
20. Chopde CT, Hote MS, Mandhane SN, Muthal AV. Giucocorticoids attenuate haloperidoMnduced catalepsy through adrenal catecholamines. J Neural Transm (Gen Sect), 1995; 102:47-54.